{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:38:59Z","timestamp":1790195939663,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ruby and Rose grant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ygyno.2014.12.031","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T01:45:16Z","timestamp":1420163116000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: Patients' and professionals' perspectives"],"prefix":"10.1016","volume":"136","clinical-trial-number":[{"clinical-trial-number":"nct01608074","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01907789","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02321228","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marieke","family":"Arts-de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marline G.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella P.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ygyno.2014.12.031_bb0005","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation\u2014positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.ygyno.2014.12.031_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","article-title":"Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations","volume":"51","author":"Brohet","year":"2014","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"10.1016\/j.ygyno.2014.12.031_bb0035","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case\u2013control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2014.12.031_bb0040","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ygyno.2014.12.031_bb0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1940-6207.CAPR-12-0190","article-title":"Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"5","author":"Fakkert","year":"2012","journal-title":"Cancer Prev Res"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.031_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ygyno.2014.12.031_bb0055","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause (NY)"},{"issue":"7","key":"10.1016\/j.ygyno.2014.12.031_bb0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-0528.2012.03324.x","article-title":"Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women","volume":"119","author":"Svejme","year":"2012","journal-title":"BJOG"},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2014.12.031_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000113718","article-title":"The long-term effects of oophorectomy on cognitive and motor aging are age dependent","volume":"5","author":"Rocca","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"4","key":"10.1016\/j.ygyno.2014.12.031_bb0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.031_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.ygyno.2014.12.031_bb0100","first-page":"1316","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc."},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.031_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 8","key":"10.1016\/j.ygyno.2014.12.031_bb0115","doi-asserted-by":"crossref","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","article-title":"Coming into focus: the nonovarian origins of ovarian cancer","volume":"24","author":"Dubeau","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.031_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/IGC.0b013e3182849dba","article-title":"Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer","volume":"23","author":"Anderson","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","article-title":"Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development","volume":"121","author":"Leblanc","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.031_bb0140","article-title":"Handboek kwalitatieve onderzoeksmethoden. 1e dr","author":"Mortelmans","year":"2007"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.031_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/intqhc\/mzh030","article-title":"Determinants of innovation within health care organizations: literature review and Delphi study","volume":"16","author":"Fleuren","year":"2004","journal-title":"Int J Qual Health Care J Int Soc Qual Health Care\/ISQua"},{"key":"10.1016\/j.ygyno.2014.12.031_bb0150","series-title":"Improving patient care: the implementation of change in clinical practice","author":"Grol","year":"2005"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.031_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","article-title":"Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers","volume":"13","author":"Beattie","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"10.1016\/j.ygyno.2014.12.031_bb0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.ygyno.2014.12.031_bb0165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.2011.573","article-title":"Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women","volume":"106","author":"Sidon","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2014.12.031_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814016291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814016291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:37:14Z","timestamp":1758771434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814016291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0090825814016291"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: Patients' and professionals' perspectives","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}